CClinicalTrials.gg
CompletedNCT01460732Updated Jul 10, 2012Results posted

Home Versus Ambulatory Monitoring, Diurnal Blood Pressure Profile, Detection of Non-Dippers

An interventional study of Blood Pressure Monitoring in Hypertension, sponsored by University of Athens. Completed at 1 site in Greece. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2012-07-10.

Sponsored by University of Athens · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
81
Allocation
Non-randomized
Ages
30 Years and older
Sex
All
01

Study summary

This is a cross-sectional study, including adults, either untreated for hypertension, or under stable treatment for more than four weeks. Assessment will include:

Clinic blood pressure measurements with an automated oscillometric device, 24-hour ambulatory blood pressure monitoring Home blood pressure monitoring during morning, evening and nocturnal measurements with the same device.

Read the detailed description

Eligible patients, as described in Inclusion/Exclusion Criteria, will be instructed to use Microlife WatchBP Home-Nocturnal oscillometric device, in order to measure their BP two times with one-minute interval, in the morning between 6 and 9 am and in the evening between 6 and 9 pm respectively for six days. These six days shall be normal working days, selected be the patient, within a time-frame of two weeks approximately. Patients should be sitting for at least five minutes and calm. During three out of those six days, they will apply and activate the same device, in order to take BP measurements while they will be asleep. Those measurements are going to be taken automatically by the device, the first 2-hours after the activation and another two with one-hour interval. Measurements will be averaged as awake and asleep BP values, with a potential to derive, if so wished, separate averages of awake-morning and awake-evening BP values.

Microlife WatchBP O3 Ambulatory Blood Pressure Measurement (ABPM) device will be applied by a doctor to each patient and it will be removed the next day by a doctor. BP measurements will be performed every 20 minutes for 24 hours. BP measurements taken during awake and asleep hours for each patient, will be analyzed separately.

Additionally, triplicate sitting Clinic Blood Pressure measurements, with one-minute interval, will be performed with the Microlife WatchBP Home-Nocturnal device during each patient's visit at the Hypertension Center. Patients will visit Hypertension Center three times, one to apply the ABPM device and one to remove it and provide the Microlife WatchBP Home-Nocturnal device and another one to bring it back. This will take approximately two weeks.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • Hypertension
  • Nocturnal BP dipping
  • Home Blood pressure Monitoring
  • Ambulatory Blood Pressure Monitoring
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 81 is close to the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

University of Athens is the lead sponsor of 133 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:ma

  • Patients referred for high blood pressure
  • Age over 30 years
  • Untreated for hypertension or under stable treatment for 4 weeks or more
  • Patients physically and mentally capable for self-measurement of blood pressure at home
  • Written informed consent to participate in the study

Exclusion Criteria:

  • Sustained arrythmia
  • Pregnancy
  • Symptomatic cardiovascular disease
  • Any other serious disease (renal failure, heart failure, malignancy)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
81 participants (actual)

Study arms

  • Other
    All patients

    All eligible patients in the study consist a single group and the same intervention is assigned to all of them.

    Device: Blood Pressure Monitoring

Interventions

  • DeviceBlood Pressure Monitoring

    Home Blood pressure Monitoring Nocturnal-Home Blood Pressure Monitoring Ambulatory Blood Pressure Monitoring

    Also known as: Microlife WatchBP Home Nocturnal, Microlife WatchBP O3

06

What researchers measure

Primary outcomes

  1. Awake Systolic Home Blood Pressure Measurement

    Awake Home Blood Pressure measurement includes duplicate BP measurements in the morning and in the evening, as per protocol.

    Time frame: 2 weeks

  2. Awake Diastolic Home Blood Pressure Measurement

    Awake Home Blood Pressure measurement includes duplicate BP measurements in the morning and in the evening, as per protocol.

    Time frame: 2 weeks

  3. Asleep Systolic Home Blood Pressure Measurement

    Home Blood Pressure measurement device was applied by the patient himself, in order to perform BP measurements during sleep, as per protocol.

    Time frame: 2 weeks

  4. Asleep Diastolic Home Blood Pressure Measurement

    Home Blood Pressure measurement device was applied by the patient himself, in order to perform BP measurements during sleep, as per protocol.

    Time frame: 2 weeks

  5. Awake Systolic Ambulatory Blood Pressure Measurement

    An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed. Measurements taken during patient's awake and asleep hours are analyzed separately.

    Time frame: 2 weeks

  6. Awake Diastolic Ambulatory Blood Pressure Measurement

    An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed. Measurements taken during patient's awake and asleep hours are analyzed separately.

    Time frame: 2 weeks

  7. Asleep Systolic Ambulatory Blood Pressure Measurement

    An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed. Measurements taken during patient's awake and asleep hours are analyzed separately.

    Time frame: 2weeks

  8. Asleep Diastolic Ambulatory Blood Pressure Measurement

    An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed. Measurements taken during patient's awake and asleep hours are analyzed separately.

    Time frame: 2weeks

Secondary outcomes

  1. Dippers Defined by ABPM and HBPM-Nocturnal

    As Dippers are defined the patients who displayed a nocturnal fall (Daytime-Nighttime BP/Daytime BP) in Systolic and/or Diastolic Blood Pressure by 10% or more, by each method. The rest of patients, with a nocturnal fall by less than 10% or even a rise of BP, are consequently defined as Non-Dippers.

    Time frame: 2 weeks

07

Results

Posted Jun 12, 2012

Participant flow

Participant flow — Overall Study
MilestoneAll Patients
Started81
Completed81
Not completed0

Outcome measures

PrimaryAwake Systolic Home Blood Pressure Measurement

Awake Home Blood Pressure measurement includes duplicate BP measurements in the morning and in the evening, as per protocol.

Time frame:
2 weeks
Reported as:
Mean · mmHg
Awake Systolic Home Blood Pressure Measurement
mmHgAll Patients
Awake Systolic Home Blood Pressure Measurement131.5 ± 11.2
PrimaryAwake Diastolic Home Blood Pressure Measurement

Awake Home Blood Pressure measurement includes duplicate BP measurements in the morning and in the evening, as per protocol.

Time frame:
2 weeks
Reported as:
Mean · mmHg
Awake Diastolic Home Blood Pressure Measurement
mmHgAll Patients
Awake Diastolic Home Blood Pressure Measurement79.9 ± 7.8
PrimaryAsleep Systolic Home Blood Pressure Measurement

Home Blood Pressure measurement device was applied by the patient himself, in order to perform BP measurements during sleep, as per protocol.

Time frame:
2 weeks
Reported as:
Mean · mmHg
Asleep Systolic Home Blood Pressure Measurement
mmHgAll Patients
Asleep Systolic Home Blood Pressure Measurement114.8 ± 12.2
PrimaryAsleep Diastolic Home Blood Pressure Measurement

Home Blood Pressure measurement device was applied by the patient himself, in order to perform BP measurements during sleep, as per protocol.

Time frame:
2 weeks
Reported as:
Mean · mmHg
Asleep Diastolic Home Blood Pressure Measurement
mmHgAll Patients
Asleep Diastolic Home Blood Pressure Measurement66.6 ± 7.9
PrimaryAwake Systolic Ambulatory Blood Pressure Measurement

An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed. Measurements taken during patient's awake and asleep hours are analyzed separately.

Time frame:
2 weeks
Reported as:
Mean · mmHg
Awake Systolic Ambulatory Blood Pressure Measurement
mmHgAll Patients
Awake Systolic Ambulatory Blood Pressure Measurement130.0 ± 11.6
PrimaryAwake Diastolic Ambulatory Blood Pressure Measurement

An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed. Measurements taken during patient's awake and asleep hours are analyzed separately.

Time frame:
2 weeks
Reported as:
Mean · mmHg
Awake Diastolic Ambulatory Blood Pressure Measurement
mmHgAll Patients
Awake Diastolic Ambulatory Blood Pressure Measurement81.0 ± 7.6
PrimaryAsleep Systolic Ambulatory Blood Pressure Measurement

An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed. Measurements taken during patient's awake and asleep hours are analyzed separately.

Time frame:
2weeks
Reported as:
Mean · mmHg
Asleep Systolic Ambulatory Blood Pressure Measurement
mmHgAll Patients
Asleep Systolic Ambulatory Blood Pressure Measurement115.2 ± 10.7
PrimaryAsleep Diastolic Ambulatory Blood Pressure Measurement

An Ambulatory Blood Pressure Measurement device is applied by a doctor to each patient for 24 hours and next day it is removed. Measurements taken during patient's awake and asleep hours are analyzed separately.

Time frame:
2weeks
Reported as:
Mean · mmHg
Asleep Diastolic Ambulatory Blood Pressure Measurement
mmHgAll Patients
Asleep Diastolic Ambulatory Blood Pressure Measurement67.6 ± 6.9
SecondaryDippers Defined by ABPM and HBPM-Nocturnal

As Dippers are defined the patients who displayed a nocturnal fall (Daytime-Nighttime BP/Daytime BP) in Systolic and/or Diastolic Blood Pressure by 10% or more, by each method. The rest of patients, with a nocturnal fall by less than 10% or even a rise of BP, are consequently defined as Non-Dippers.

Time frame:
2 weeks
Reported as:
Number · percentage of patients
Dippers Defined by ABPM and HBPM-Nocturnal
percentage of patientsABPMHBPM-Nocturnal
Dippers Defined by ABPM and HBPM-Nocturnal8478

Adverse events

Non-serious events are listed at a 0.1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
All Patients—0/81 (0%)0/81 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)All Patients
<=18 years0
Between 18 and 65 years62
>=65 years19
Age Continuous
Age Continuous(years)All Patients
Mean58.1 ± 10.7
Sex: Female, Male
Sex: Female, Male(Participants)All Patients
Female38
Male43
Region of Enrollment
Region of Enrollment(participants)All Patients
Greece81
08

Study locations

1 site
  • Sotiria General Hospital
    Athens, 11527, Greece
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 10, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01460732
Lead sponsor
University of Athens
Responsible party
George S. Stergiou (Associate Professor of Medicine and Hypertension, University of Athens) — Principal investigator
First posted
Oct 27, 2011
Start date
Nov 2010
Primary completion
Dec 2011
Completion
Dec 2011
Results posted
Jun 12, 2012
Last update
Jul 10, 2012

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion